Costs of different strategies for neonatal hearing screening: a modelling approach
H C Boshuizena, G J van der Lemb, M A Kauffman-de Boerb, G A van Zantenc, A M Oudesluys-Murphyd, P H Verkerke
a TNO Prevention and
Health, Division of Public Health, Leiden, The Netherlands, b Dutch foundation of the Deaf and Hard
of Hearing Child, c Department of Audiology, Academic Hospital
Rotterdam/Sophia Children Hospital/Erasmus University Rotterdam,
Rotterdam, The Netherlands, d Department
of Paediatrics, Medical Center Rijnmond-Zuid, Location Zuider,
Rotterdam, e TNO
Prevention and Health, Division of Child Health and Health Care, Leiden
Correspondence to: Dr Boshuizen, National Institute of Public Health and the Environment, Computerisation and Methodological Consultancy Unit, PO Box 1, NL-3720 BA Bilthoven, The Netherlands Hendriek.Boshuizen{at}RIVM.NL
Accepted 6 July 2001
OBJECTIVE
To compare
the cost effectiveness of various strategies for neonatal hearing
screening by estimating the cost per hearing impaired child detected.
DESIGN
Cost analyses
with a simulation model, including a multivariate sensitivity analysis.
Comparisons of the cost per child detected were made for: screening
method (automated auditory brainstem response or otoacoustic
emissions); number of stages in the screening process (two or three);
target disorder (bilateral hearing loss or both unilateral and
bilateral loss); location (at home or at a child health clinic).
SETTING
The
Netherlands
TARGET POPULATION
All
newborn infants not admitted to neonatal intensive care units.
MAIN OUTCOME
MEASURE
Costs per child detected with a hearing
loss of 40 dB or more in the better ear.
RESULTS
Costs of a
three stage screening process in child health clinics are
39.0 (95%
confidence interval 20.0 to 57.0) per child detected with automated
auditory brainstem response compared with
25.0 (14.4 to 35.6) per
child detected with otoacoustic emissions. A three stage screening
process not only reduces the referral rates, but is also likely to cost
less than a two stage process because of the lower cost of diagnostic
facilities. The extra cost (over and above a screening programme
detecting bilateral losses) of detecting one child with unilateral
hearing loss is
1500-4000. With the currently available
information, no preference can be expressed for a screening location.
CONCLUSIONS
Three
stage screening with otoacoustic emissions is recommended. Whether
screening at home is more cost effective than screening at a child
health clinic needs further study.
Keywords: costs; hearing; screening; otoacoustic emissions; automated auditory brainstem response
© 2001 by Archives of Disease in Childhood
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



